Yann Cao | wireless communication | Best Researcher Award

Mrs. Yann Cao| wireless communication | Best Researcher Award

Teacher | Tianjin normal university | China

Mrs. Yanan Cao is a multidisciplinary researcher recognized for significant contributions spanning genomics, computational biology, artificial intelligence, and materials science. Affiliated with the University of Kentucky, Mrs. Yanan Cao’s work has garnered substantial academic impact, reflected in over 1,800 citations. Her early research made major advances in medical genetics, including the discovery of the  mutation linked to adrenal Cushing’s syndrome and the mutation in insulinoma, both published in Science and Nature. She later expanded her focus to large-scale population genomics through projects such as the China Map initiative, analyzing deep whole-genome sequences for metabolic and genetic insights. In computational research, Mrs. Yanan Cao has contributed to document-level relation extraction and graph neural network–based fraud detection, demonstrating expertise in machine learning and data-driven modeling. More recently, her collaborative work in energy materials has produced breakthroughs in hydrogen evolution catalysis and single-atom catalysts. Mrs. Yanan Cao’s interdisciplinary research portfolio reflects a strong emphasis on integrating computational methods with experimental and biomedical sciences to advance precision medicine and sustainable technologies.

Profile : Google Scholar
Featured Publication
  • Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., Zhou, W., Li, X., Zhong, X., Lei, Y., Su, T., Wang, H., Jiang, Y., Yang, L., Wei, W., Yang, X., … Ning, G. (2014). Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome. Science, 344(6186), 913–917.

  • Cao, Y., Li, L., Xu, M., Feng, Z., Sun, X., Lu, J., Xu, Y., Du, P., … (2020). The China Map analytics of deep whole genome sequences in 10,588 individuals. Cell Research.

  • Cao, Y., Li, L., Feng, Z., Wan, S., Huang, P., Sun, X., Wen, F., … (2020). Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discovery, 6, 11.

  • Cao, Y., Ye, Q., Ma, M., & She, Q.-B. (2023). Enhanced bypass of PD-L1 translation reduces the therapeutic response to mTOR kinase inhibitors.